BioImagene Inc., a digital pathology solutions provider, announced a collaboration with the University of Pennsylvania School (UPenn) of Medicine and Rutgers, The State University of New Jersey to develop Companion Algorithms for next generation companion diagnostics for digital pathology.
The collaboration is applies BioImagene's iAnalytics framework to develop next-generation analysis, quantification and decision support tools for anatomical pathology. Researchers and clinicians from UPenn and Rutgers University will digitize standard prostate biopsy samples using BioImagene's Virtuoso framework. They will also use BioImagene's telepathology capabilities to collaborate on development and validation of algorithms for diagnostic use. Read more about BioImagene's digital pathology solutions here.
"This collaboration marks the first step towards quantitative histoimaging in prostate cancer," said John E. Tomaszewski, MD, professor of Pathology and Laboratory Medicine at UPenn. "Our goal is to improve the quality of prostate biopsy diagnostics by developing quantitative and reproducible algorithms that go beyond Gleason Grading, to be even more predictive of treatment outcomes."